Endoscopic submucosal dissection in rectal tumors extending or not to the dentate line: A comparative analysis.


Journal

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
ISSN: 1878-3562
Titre abrégé: Dig Liver Dis
Pays: Netherlands
ID NLM: 100958385

Informations de publication

Date de publication:
03 2020
Historique:
received: 19 05 2019
revised: 13 09 2019
accepted: 12 10 2019
pubmed: 21 11 2019
medline: 21 1 2021
entrez: 21 11 2019
Statut: ppublish

Résumé

The feasibility of endoscopic submucosal dissection (ESD) in rectal tumors extending to the dentate line (RTDL) is unclear. To analyze the outcomes of ESD in RTDL compared to non-RTDL, with a special focus on the lower rectum location. Observational multicenter retrospective study. All patients with a rectal tumor who underwent ESD in 2013-2017 were included. A comparative analysis between RTDL and non-RTDL groups was done. Two-hundred and twenty-eight patients (median age: 69 years, range: 33-89, 51.3% male) with RTDL (n = 65, 28.5%) and non-RTDL lesions (n = 163, 71.5%) were included. There were no significant differences between the en-bloc (89.2% vs. 90.8%, p = 0.718), complete (60% vs. 71.8%, p = 0.084) and curative resection rates (58.5% vs. 68.7%, p = 0.141). The overall complication rate (4.6% vs. 8%, p = 0.370) was not different, independently of the rectal location. Local recurrence was higher in RTDL (7.3% vs. 1.5%, p = 0.065). The indication for surgery due to non-curative resections in the lower rectum was lower in RTDL (9.2% vs. 14.6%, p = 0.378). The safety, effectiveness and long-term impact of ESD in RTDL and non-RTDLs is comparable. Local recurrence in the lower rectum may be higher in RTDL.

Sections du résumé

BACKGROUND
The feasibility of endoscopic submucosal dissection (ESD) in rectal tumors extending to the dentate line (RTDL) is unclear.
AIMS
To analyze the outcomes of ESD in RTDL compared to non-RTDL, with a special focus on the lower rectum location.
METHODS
Observational multicenter retrospective study. All patients with a rectal tumor who underwent ESD in 2013-2017 were included. A comparative analysis between RTDL and non-RTDL groups was done.
RESULTS
Two-hundred and twenty-eight patients (median age: 69 years, range: 33-89, 51.3% male) with RTDL (n = 65, 28.5%) and non-RTDL lesions (n = 163, 71.5%) were included. There were no significant differences between the en-bloc (89.2% vs. 90.8%, p = 0.718), complete (60% vs. 71.8%, p = 0.084) and curative resection rates (58.5% vs. 68.7%, p = 0.141). The overall complication rate (4.6% vs. 8%, p = 0.370) was not different, independently of the rectal location. Local recurrence was higher in RTDL (7.3% vs. 1.5%, p = 0.065). The indication for surgery due to non-curative resections in the lower rectum was lower in RTDL (9.2% vs. 14.6%, p = 0.378).
CONCLUSION
The safety, effectiveness and long-term impact of ESD in RTDL and non-RTDLs is comparable. Local recurrence in the lower rectum may be higher in RTDL.

Identifiants

pubmed: 31744774
pii: S1590-8658(19)30873-4
doi: 10.1016/j.dld.2019.10.009
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

296-300

Informations de copyright

Copyright © 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Auteurs

Déborah Roland (D)

Department of Gastroenterology and Endoscopy, Georges-Pompidou European Hospital, Paris, France.

Gabriel Rahmi (G)

Department of Gastroenterology and Endoscopy, Georges-Pompidou European Hospital, Paris, France. Electronic address: gabriel.rahmi@aphp.fr.

Enrique Pérez-Cuadrado-Robles (E)

Department of Gastroenterology and Endoscopy, Georges-Pompidou European Hospital, Paris, France.

Guillaume Perrod (G)

Department of Gastroenterology and Endoscopy, Georges-Pompidou European Hospital, Paris, France.

Jérémie Jacques (J)

Department of Gastroenterology, Dupuytren University Hospital, Limoges, France.

Maximilien Barret (M)

Department of Gastroenterology, Cochin Hospital, Paris, France.

Sarah Leblanc (S)

Department of Gastroenterology, Cochin Hospital, Paris, France.

Arthur Berger (A)

Department of Gastroenterology and Endoscopy, Georges-Pompidou European Hospital, Paris, France.

Jérémie Albouys (J)

Department of Gastroenterology, Dupuytren University Hospital, Limoges, France.

Stanislas Chaussade (S)

Department of Gastroenterology, Cochin Hospital, Paris, France.

Christophe Cellier (C)

Department of Gastroenterology and Endoscopy, Georges-Pompidou European Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH